In This Edition

Key Takeaways

Global stocks plummet amid growing fears of recession, expectations of US Federal Reserve policy hardening. Ukraine marks 31 years of independence, vowing to liberate all territory from Russian occupation. Europe is facing its worst drought in at least 500 years, with two-thirds of the continent in a state of alert or warning. Analysis: COVID-19 Update: Omicron-Specific Boosters Weeks Away.

Condition Updates

A rundown of important global risk developments in markets, in business, and region by region.

Analysis: COVID-19 Update: Omicron-Specific Boosters Weeks Away

Last week, the UK became the first country to authorize long-awaited Omicron-specific boosters, and countries like Canada and Australia are likely to follow soon. Earlier this week, Pfizer-BioNTech and Moderna formally requested FDA approval for the Omicron-targeted shots, and the FDA is expected to grant the authorization within weeks. These variant-specific boosters are seen by many as the future of pandemic management, as well as a realization of the initial promise of adaptable mRNA vaccines.

Download the article